| Garvieacin Q, a novel class II bacteriocin from Lactococcus garvieae BCC 43578. | |
| | |
MedLine Citation:
|
PMID: 22210221 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Lactococcus garvieae BCC 43578 produces a novel class II bacteriocin, garvieacin Q (GarQ) of 70 amino acids containing a 20 amino acids N-terminal leader peptide, which is cleaved at Gly-Gly site to generate the mature GarQ (5,339 Da), especially inhibitory against Listeria monocytogenes ATCC 19115 and other L. garvieae strains. |
| | |
Authors:
|
Amonlaya Tosukhowong; Takeshi Zendo; Wonnop Visessanguan; Sittiruk Roytrakul; Laphaslada Pumpuang; Janthima Jaresitthikunchai; Kenji Sonomoto |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-12-30 |
Journal Detail:
|
Title: Applied and environmental microbiology Volume: - ISSN: 1098-5336 ISO Abbreviation: - Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2012-1-2 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7605801 Medline TA: Appl Environ Microbiol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Thailand. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Wolbachia strain wAlbB enhances infection by the rodent malaria parasite Plasmodium berghei in Anoph...
Next Document: Construction of a genetic linkage map based on AFLP markers and development of STS markers for marke...